Pediatric empyemas – Has the pendulum swung too far?

National database analysis of 3,365 pediatric empyema cases reveals that while fibrinolytic therapy use increased to 95% by 2017, primary VATS demonstrates superior outcomes including shorter hospital stays, reduced PICU admissions, and less mechanical ventilation. Authors advocate for risk stratification to identify children who would benefit from upfront surgical intervention.